High-throughput "read-on-ski" automated imaging and label-free detection system for toxicity screening of compounds

Qizheng Wang1, Jun Lu2,3, Ke Fan2

  • 1State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.

Insights

Researchers developed an automated imaging system for rapid, high-accuracy kidney organoid screening. This innovation accelerates toxicity studies and drug discovery using personalized stem cell models.

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Toxicology

Background:

  • Organoid models, particularly human pluripotent stem cell-derived kidney organoids, are crucial for studying kidney physiology and disease.
  • Current methods for assessing nephrotoxicity and compound effects in organoids are often slow, hindering research acceleration.

Purpose of the Study:

  • To develop an automated, high-throughput imaging system for kidney organoids.
  • To enhance the speed and accuracy of toxicity assessments in organoid models for drug discovery and translational research.

Main Methods:

  • An automated continuous imaging setup utilizing the "read-on-ski" control law was developed to minimize vibration and maximize temporal resolution.
  • High-resolution (1.1 μm) imaging of entire multi-well plates was achieved in under 3 minutes.
  • Machine learning-based classification and segmentation algorithms processed acquired images for toxicity determination.

Main Results:

  • The system achieved high-accuracy performance in screening and imaging kidney organoids.
  • Cisplatin-induced nephrotoxicity was evaluated in kidney organoids with 95% accuracy using the automated system.
  • Label-free, non-invasive algorithms combined with the imaging device provided results verified by conventional biological methods.

Conclusions:

  • The developed automated "read-on-ski" imaging system significantly accelerates kidney organoid screening and toxicity assessment.
  • This technology facilitates scaled-up screening for basic research and drug discovery, leveraging the in vivo-like nature of organoid models.

Related Concept Videos